Analysen zu BioNTech (ADRs)
| 04.11.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 03.10.24 | BioNTech Buy | Deutsche Bank AG | |
| 02.10.24 | BioNTech Neutral | UBS AG | |
| 19.09.24 | BioNTech Buy | Deutsche Bank AG | |
| 18.09.24 | BioNTech Neutral | UBS AG | |
| 17.09.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 16.09.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 13.09.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 09.09.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 16.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 16.08.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 06.08.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 24.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 10.05.24 | BioNTech Neutral | UBS AG | |
| 08.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 07.05.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 06.05.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 23.04.24 | BioNTech Hold | Deutsche Bank AG | |
| 22.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 20.03.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 20.03.24 | BioNTech Neutral | UBS AG |
Aktuelle Aktienanalysen
| 04.03.26 | Rolls-Royce Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.03.26 | Brenntag Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | BASF Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | Redcare Pharmacy Buy | Baader Bank | |
| 04.03.26 | Redcare Pharmacy Overweight | Barclays Capital | |
| 04.03.26 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 04.03.26 | Grand City Properties Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.03.26 | Symrise Underperform | Jefferies & Company Inc. | |
| 04.03.26 | Fresenius Overweight | Barclays Capital | |
| 04.03.26 | Sixt Buy | UBS AG | |
| 04.03.26 | Aroundtown Neutral | UBS AG | |
| 04.03.26 | Symrise Buy | UBS AG | |
| 04.03.26 | Grand City Properties Neutral | UBS AG | |
| 04.03.26 | Schaeffler Sell | UBS AG | |
| 04.03.26 | Evonik Neutral | UBS AG | |
| 04.03.26 | Bilfinger Neutral | UBS AG | |
| 04.03.26 | Redcare Pharmacy Neutral | UBS AG | |
| 04.03.26 | Continental Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | Continental Market-Perform | Bernstein Research | |
| 04.03.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | Österreichische Post neutral | Erste Group Bank | |
| 04.03.26 | Bayer Hold | Jefferies & Company Inc. | |
| 04.03.26 | adidas Buy | Deutsche Bank AG | |
| 04.03.26 | TRATON Hold | Jefferies & Company Inc. | |
| 04.03.26 | adidas Buy | Jefferies & Company Inc. | |
| 04.03.26 | TRATON Market-Perform | Bernstein Research | |
| 04.03.26 | Symrise Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | TRATON Neutral | JP Morgan Chase & Co. | |
| 04.03.26 | Aroundtown Underperform | Jefferies & Company Inc. | |
| 04.03.26 | Bayer Overweight | Barclays Capital | |
| 04.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | adidas Sector Perform | RBC Capital Markets | |
| 04.03.26 | TRATON Neutral | Goldman Sachs Group Inc. | |
| 04.03.26 | adidas Neutral | Goldman Sachs Group Inc. | |
| 04.03.26 | Aroundtown Neutral | Goldman Sachs Group Inc. | |
| 04.03.26 | AUTO1 Buy | Deutsche Bank AG | |
| 04.03.26 | Symrise Equal Weight | Barclays Capital | |
| 04.03.26 | Continental Buy | Jefferies & Company Inc. | |
| 04.03.26 | flatexDEGIRO Buy | Deutsche Bank AG | |
| 04.03.26 | Schaeffler Hold | Deutsche Bank AG | |
| 04.03.26 | HelloFresh Hold | Deutsche Bank AG | |
| 04.03.26 | Symrise Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | Befesa Hold | Deutsche Bank AG | |
| 04.03.26 | Münchener Rückversicherungs-Gesellschaft Neutral | Goldman Sachs Group Inc. | |
| 04.03.26 | Apple Neutral | UBS AG | |
| 04.03.26 | BASF Neutral | UBS AG | |
| 04.03.26 | Beiersdorf Sell | UBS AG | |
| 04.03.26 | Beiersdorf Buy | Goldman Sachs Group Inc. | |
| 04.03.26 | Evonik Underperform | Jefferies & Company Inc. | |
| 04.03.26 | Santander Overweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.